Julie A. Cullivan
Known title: DirectorCIK: 0001713207
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Axon Gains Momentum After Multiple Federal Contracts. Axon Enterprise has secured new contracts from several U.S. federal agencies, boosting its federal sector momentum as the fiscal year ends. The company’s recent wins have drawn increased analyst coverage and investor interest. These developments come while the stock trades near its 52‑week low and shows a volume spike. The news highlights the firm’s expanding role in government security solutions.
Transaction History
| HTFL | ▼ Sell | Open Market | 9,122 | $228K | 3/5/2026 | View on chart |
| HTFL | ▼ Sell | Open Market | 8,000 | $219K | 2/5/2026 | View on chart |
| AXON | ▲ Buy | Grant | 446 | $0 | 5/29/2025 | View on chart |
| AXON | ▼ Sell | Open Market | 657 | $460K | 5/12/2025 | View on chart |
| AXON | ▼ Sell | Open Market | 1,261 | $860K | 12/4/2024 | View on chart |
| AXON | ▼ Sell | Open Market | 900 | $318K | 9/5/2024 | View on chart |
| AXON | ▼ Sell | Open Market | 993 | $280K | 5/31/2024 | View on chart |
| AXON | ▼ Sell | Open Market | 478 | $137K | 5/28/2024 | View on chart |
| AXON | ▲ Buy | Grant | 657 | $0 | 5/10/2024 | View on chart |
| AXON | ▼ Sell | Open Market | 515 | $110K | 9/11/2023 | View on chart |
| AXON | ▼ Sell | Open Market | 1,180 | $231K | 5/30/2023 | View on chart |
| AXON | ▼ Sell | Open Market | 2,013 | $398K | 5/22/2023 | View on chart |
| AXON | ▲ Buy | Grant | 993 | $0 | 5/12/2023 | View on chart |
| AXON | ▼ Sell | Open Market | 1,502 | $153K | 5/31/2022 | View on chart |
| AXON | ▼ Sell | Open Market | 478 | $48K | 5/27/2022 | View on chart |
| AXON | ▲ Buy | Grant | 2,013 | $200K | 5/20/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Heartflow featured in AI healthcare stock roundup
Heartflow was included in a recent Yahoo Finance article highlighting top AI healthcare stocks alongside Pfizer and another company. This mention places the firm in the conversation regarding artificial intelligence applications in the medical sector. The stock currently trades within its 52-week range, with analysts maintaining an average price target of $46.00.
Heartflow featured in AI healthcare stock roundup. Heartflow was included in a recent Yahoo Finance article highlighting top AI healthcare stocks alongside Pfizer and another company. This mention places the firm in the conversation regarding artificial intelligence applications in the medical sector. The stock currently trades within its 52-week range, with analysts maintaining an average price target of $46.00.